NCT01769235 - Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris | Biotech Hunter

Enrollment

1,215

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions

Acne Vulgaris

Interventions

DRUG

Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%

Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% (Taro Pharmaceuticals Inc.)applied at approximately the same time once daily for 84 days (12 weeks).

DRUG

Acanya® Gel, 1.2%/2.5%

Acanya® (Clindamycin Phosphate and Benzoyl Peroxide) Gel, 1.2%/2.5% (Dow Pharmaceutical Sciences, Inc., marketed by Valeant Pharmaceuticals North America LLC)applied at approximately the same time once daily for 84 days (12 weeks).

DRUG

Vehicle of test product

Vehicle of test product (Taro Pharmaceuticals Inc.)applied at approximately the same time once daily for 84 days (12 weeks).

All Listed Sponsors

lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY